Lancet31 Aug 2026
In patients with advanced hepatocellular carcinoma who responded to systemic therapy, surgical resection significantly prolongs time to treatment failure compared to maintenance therapy.
Br J Surg31 Aug 2026
A new classification system called DISH (Dehiscence, Infection, Seroma, Haematoma) standardizes the reporting of surgical site outcomes, enhancing clinical management and research.
Ann Surg Oncol31 Aug 2026
Patients with pancreaticobiliary maljunction (PBM) have significantly worse recurrence-free survival following surgical resection for gallbladder carcinoma without hepaticojejunostomy.
Ann Surg Oncol31 Aug 2026
A counterclockwise, step-by-step approach for robotic pancreatoduodenectomy enhances surgical workflow and appears to reduce operative complications.
Dis Colon Rectum31 Aug 2026
Using biological mesh for pelvic floor reconstruction after extralevator abdominoperineal resection in low rectal cancer patients does not provide a cost-effective solution despite slightly reducing perineal complications.
Gastrointest Endosc28 Aug 2026
ERCP is a highly effective and safe option for managing symptomatic cystic duct remnant stones in post-cholecystectomy patients, reducing the need for surgical excision.
Ann Surg Oncol28 Aug 2026
Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.
Ann Surg Oncol28 Aug 2026
Surgeons are familiar with intraoperative cell salvage (ICS) but use it sparingly during liver resections for cancer due to concerns about tumor cell contamination, indicating a need for more robust oncological outcome data.
Ann Surg Oncol28 Aug 2026
Utilizing an artery-first approach for distal pancreatectomy with celiac axis resection can effectively manage blood loss and maintain low mortality in pancreatic cancer surgery.
Ann Surg Oncol28 Aug 2026
Curative surgery for locally recurrent rectal cancer (LRRC) is yielding better long-term outcomes, with a significant increase in the R0 resection rate and overall survival.